Rachel Kotok Goldberg Shares Developing Evidence-Based Behavioral Health Programs for Horizon Has Been a Great Career Accomplishment

Ibtrozi had a 90% response rate in treatment naïve adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer, according to the results of a news release.

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.

Enflonsia is the first FDA-approved respiratory syncytial virus (RSV) preventative for infants, regardless of weight, according to the news release.

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.

GLP-1 drugs such as Ozempic and Mounjaro outperformed metformin, statins and insulin in lowering rates of age-related macular degeneration and primary open-angle glaucoma.

Executive vice president of artificial intelligence, Altera Digital Health. Altera Digital Health provides digital services to healthcare clients.